Atreus Pharmaceuticals Overview

  • Founded
  • 2007

Founded
  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Corporate

  • Financing Rounds
  • 2

Atreus Pharmaceuticals General Information

Description

Operator of a biopharmaceutical company focused on developing in-vivo radiopharmaceutical products. The company develops products suitable for nuclear medicine (SPECT) imaging that aid in the early diagnosis and management of diseases including rheumatoid arthritis, helping its clients with early diagnosis and management of diseases including rheumatoid arthritis.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • 9 Hansen Avenue
  • Ottawa, Ontario K2K 2L9
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Atreus Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Atreus Pharmaceuticals‘s full profile, request access.

Request a free trial